| Primary |
| Prostate Cancer |
49.0% |
| Product Used For Unknown Indication |
19.7% |
| Hypertension |
4.7% |
| Dysmenorrhoea |
4.0% |
| Drug Use For Unknown Indication |
3.0% |
| Leiomyoma |
2.3% |
| Endometriosis |
1.7% |
| Prophylaxis |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Breast Cancer Female |
1.3% |
| Gastric Disorder |
1.3% |
| Hypercholesterolaemia |
1.3% |
| Menorrhagia |
1.3% |
| Blood Pressure |
1.0% |
| Breast Cancer |
1.0% |
| Ear Infection Viral |
1.0% |
| In Vitro Fertilisation |
1.0% |
| Nausea |
1.0% |
| Osteoporosis Prophylaxis |
1.0% |
| Precocious Puberty |
1.0% |
|
| Death |
75.2% |
| Hospitalisation |
2.5% |
| Terminal State |
2.5% |
| Hot Flush |
1.9% |
| Hysterectomy |
1.9% |
| Investigation |
1.9% |
| Nausea |
1.9% |
| Urinary Retention |
1.9% |
| Loss Of Consciousness |
1.2% |
| Prostate Cancer |
1.2% |
| Urinary Incontinence |
1.2% |
| Visual Impairment |
1.2% |
| Weight Increased |
1.2% |
| Abdominal Pain Upper |
0.6% |
| B-cell Lymphoma |
0.6% |
| Blood Calcium Decreased |
0.6% |
| Chemotherapy |
0.6% |
| Depression |
0.6% |
| Fall |
0.6% |
| Fatigue |
0.6% |
|
| Secondary |
| Prostate Cancer |
18.4% |
| Dysmenorrhoea |
16.3% |
| Product Used For Unknown Indication |
15.0% |
| Metastases To Bone |
6.8% |
| Endometriosis |
4.8% |
| Gastric Disorder |
4.8% |
| Prophylaxis |
4.8% |
| Ear Infection Viral |
4.1% |
| Nausea |
4.1% |
| Osteoporosis Prophylaxis |
4.1% |
| Seasonal Allergy |
4.1% |
| Tympanic Membrane Disorder |
4.1% |
| Leiomyoma |
3.4% |
| Menorrhagia |
1.4% |
| Asthma |
0.7% |
| Breast Cancer |
0.7% |
| Cardiac Disorder |
0.7% |
| Constipation |
0.7% |
| Contraception |
0.7% |
| Depression |
0.7% |
|
| Non-cardiac Chest Pain |
34.5% |
| Nausea |
13.8% |
| Gallbladder Disorder |
6.9% |
| Hysterectomy |
6.9% |
| Depression |
3.4% |
| Hypoaesthesia |
3.4% |
| Injection Site Scar |
3.4% |
| Interstitial Lung Disease |
3.4% |
| Menstruation Irregular |
3.4% |
| Metastases To Lung |
3.4% |
| Polyneuropathy |
3.4% |
| Sinus Tachycardia |
3.4% |
| Tendon Rupture |
3.4% |
| Tinnitus |
3.4% |
| Weight Increased |
3.4% |
|
| Concomitant |
| Prostate Cancer |
31.6% |
| Prostate Cancer Metastatic |
14.5% |
| Metastases To Bone |
9.3% |
| In Vitro Fertilisation |
7.3% |
| Pain |
5.7% |
| Hypertension |
3.6% |
| Prophylaxis |
3.6% |
| Assisted Fertilisation |
3.1% |
| Depression |
3.1% |
| Hormone Therapy |
3.1% |
| Gastrointestinal Disorder Therapy |
2.1% |
| Hormone Replacement Therapy |
2.1% |
| Mineral Supplementation |
2.1% |
| Product Used For Unknown Indication |
2.1% |
| Anaemia |
1.6% |
| Arrhythmia |
1.0% |
| Asthma |
1.0% |
| Back Pain |
1.0% |
| Gout |
1.0% |
| Hypopituitarism |
1.0% |
|
| Pain In Jaw |
15.1% |
| Vomiting |
11.3% |
| Osteonecrosis |
9.4% |
| Ovarian Cyst |
7.5% |
| Pneumothorax |
7.5% |
| Soft Tissue Infection |
5.7% |
| Dehydration |
3.8% |
| Intestinal Obstruction |
3.8% |
| Jaundice |
3.8% |
| Maternal Exposure During Pregnancy |
3.8% |
| Medulloblastoma |
3.8% |
| Oedema Peripheral |
3.8% |
| Osteonecrosis Of Jaw |
3.8% |
| Tooth Extraction |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Cellulitis |
1.9% |
| Colon Cancer |
1.9% |
| Decreased Appetite |
1.9% |
| Diabetic Foot |
1.9% |
| Dyspnoea |
1.9% |
|
